<?xml version="1.0" encoding="UTF-8"?>
<ref id="B9-nanomaterials-10-01072">
 <label>9.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Cojocaru</surname>
    <given-names>F.-D.</given-names>
   </name>
   <name>
    <surname>Botezat</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Gardikiotis</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Uritu</surname>
    <given-names>C.-M.</given-names>
   </name>
   <name>
    <surname>Dodi</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Trandafir</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Rezus</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Rezus</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Tamba</surname>
    <given-names>B.-I.</given-names>
   </name>
   <name>
    <surname>Mihai</surname>
    <given-names>C.-T.</given-names>
   </name>
  </person-group>
  <article-title>Nanomaterials designed for antiviral drug delivery transport across biological barriers</article-title>
  <source>Pharmaceutics</source>
  <year>2020</year>
  <volume>12</volume>
  <elocation-id>171</elocation-id>
  <pub-id pub-id-type="doi">10.3390/pharmaceutics12020171</pub-id>
 </element-citation>
</ref>
